Mayte Pérez-Olmeda

Mayte Pérez-Olmeda

UNVERIFIED PROFILE

Are you Mayte Pérez-Olmeda?   Register this Author

Register author
Mayte Pérez-Olmeda

Mayte Pérez-Olmeda

Publications by authors named "Mayte Pérez-Olmeda"

Are you Mayte Pérez-Olmeda?   Register this Author

22Publications

198Reads

13Profile Views

Genetic and phenotypic analyses of sequential vpu alleles from HIV-infected IFN-treated patients.

Virology 2017 01 15;500:247-258. Epub 2016 Nov 15.

INSERM, U941, Paris F-75010, France; Univ Paris Diderot, Sorbonne Paris Cité, F-75475 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.virol.2016.10.028DOI Listing
January 2017

Hydroxytyrosol: a new class of microbicide displaying broad anti-HIV-1 activity.

AIDS 2016 11;30(18):2767-2776

aAIDS Immunopathology Department, National Centre of Microbiology, Instituto de Salud Carlos III bPharmacology Department, Pharmacy Faculty, Universidad Complutense de Madrid cSeprox Biotech, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106087PMC
November 2016

Determination of HIV tropism and its use in the clinical practice.

Expert Rev Anti Infect Ther 2013 Dec 6;11(12):1291-302. Epub 2013 Nov 6.

AIDS Immunopathogenesis Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Crtra. Majadahonda Pozuelo Km2, 28220, Majadahonda, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14787210.2013.852469DOI Listing
December 2013

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy.

Retrovirology 2012 Aug 13;9:68. Epub 2012 Aug 13.

Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investigaciones Científicas & Universidad Autónoma de Madrid, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1742-4690-9-68DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468358PMC
August 2012

A sensitive phenotypic assay for the determination of human immunodeficiency virus type 1 tropism.

J Antimicrob Chemother 2010 Dec 14;65(12):2493-501. Epub 2010 Oct 14.

AIDS Immunopathology Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkq379DOI Listing
December 2010

Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs.

Nat Rev Microbiol 2009 Nov;7(11):798-812

AIDS Immunopathology Unit, National Centre of Microbiology, Instituto de Salud Carlos III, 28220 Majadahonda, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrmicro2223DOI Listing
November 2009

[Methods for determining viral tropism: genotype and phenotype tests].

Enferm Infecc Microbiol Clin 2008 Oct;26 Suppl 11:40-8

Unidad de Inmunopatologia del Sida, Instituto de Salud Carlos III, Madrid, España.

View Article

Download full-text PDF

Source
October 2008

Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression.

Proteomics 2006 Apr;6 Suppl 1:S63-73

AIDS Immunopathology Unit, National Centre of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pmic.200500437DOI Listing
April 2006

Management of chronic hepatitis C in patients co-infected with HIV: focus on safety considerations.

Drug Saf 2004 ;27(1):7-24

Gastroenterology and Hepatology Department, Hospital Carlos III, Instituto de Salud Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00002018-200427010-00002DOI Listing
May 2004

Hepatitis C virus (HCV) relapses after anti-HCV therapy are more frequent in HIV-infected patients.

AIDS Res Hum Retroviruses 2004 Apr;20(4):351-3

Service of Infectious Diseases, Instituto de Salud Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/088922204323048096DOI Listing
April 2004

Distribution of hepatitis B virus genotypes in HIV-infected patients with chronic hepatitis B: therapeutic implications.

AIDS Res Hum Retroviruses 2003 Aug;19(8):657-9

Service of Infectious Diseases, Instituto de Salud Carlos III, 28035 Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/088922203322280874DOI Listing
August 2003

Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine.

AIDS 2002 Nov;16(17):2352-4

Service of Infectious Diseases, Instituto de Salud Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
November 2002

Liver injury after beginning antiretroviral therapy in HIV/hepatitis C virus co-infected patients is not related to immune reconstitution.

AIDS 2002 Jul;16(10):1423-5

Service of Infectious Diseases. Hospital Carlos III, Instituto de Salud Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
July 2002

Role of hepatitis C virus genotype in the development of severe transaminase elevation after the introduction of antiretroviral therapy.

J Acquir Immune Defic Syndr 2002 May;30(1):65-8

Service of Infectious Diseases, Hospital Carlos III, Instituto de Salud Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
May 2002

Virological characteristics of hepatitis C virus infection in HIV-infected individuals with chronic hepatitis C: implications for treatment.

AIDS 2002 Feb;16(3):493-5

Infectious Disease Service, Hepatology Unit, Institute de Salud Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
February 2002